Colistin, mechanisms and prevalence of resistance

AZ Bialvaei, H Samadi Kafil - Current medical research and …, 2015 - Taylor & Francis
Background: Infections caused by multi-drug-resistant Gram-negative bacteria, particularly
Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae, that …

[HTML][HTML] Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns

M Assefa - Pneumonia, 2022 - Springer
Bacterial pneumonia is one of the most serious public health issues owing to its medical and
economic costs, which result in increased morbidity and mortality in people of all ages …

New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse …

SE Cheah, J Wang, VTT Nguyen… - Journal of …, 2015 - academic.oup.com
Objectives This study investigated the exposure–response relationships between unbound
colistin in plasma and antibacterial activity in mouse thigh and lung infections. Methods …

[HTML][HTML] Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins

F Wagenlehner, E Lucenteforte, F Pea… - Clinical Microbiology …, 2021 - Elsevier
Background Nephrotoxicity and neurotoxicity are commonly associated with polymyxin
treatment; however, the emergence of multidrug-resistant Gram-negative bacteria with …

[HTML][HTML] Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial

S Abdellatif, A Trifi, F Daly, K Mahjoub, R Nasri… - Annals of intensive …, 2016 - Springer
Background Cases of ventilator-associated pneumonia (VAP) due to multidrug-resistant
(MDR) gram-negative bacilli (GNB) mainly Acinetobacter baumannii, Pseudomonas …

High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part …

A Pérez, E Gato, J Pérez-Llarena… - Journal of …, 2019 - academic.oup.com
Objectives To characterize the antimicrobial susceptibility, molecular epidemiology and
carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates recovered from …

Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models

CB Landersdorfer, J Wang, V Wirth… - Journal of …, 2018 - academic.oup.com
Background The pharmacokinetic/pharmacodynamic (PK/PD) relationship for polymyxin B
against Klebsiella pneumoniae infections is not known. Methods Dose-fractionation studies …

Пневмония: актуальная проблема медицины ХХΙ века

АГ Чучалин - Пульмонология, 2015 - journal.pulmonology.ru
Аннотация Обсуждаются систематические обзоры и метаанализы последних лет,
посвященные пневмонии. Заболеваемость пневмонией в Европе и Северной Америке …

[HTML][HTML] What's new in multidrug-resistant pathogens in the ICU?

G Zilahi, A Artigas, I Martin-Loeches - Annals of intensive care, 2016 - Springer
Over the last several decades, antibacterial drug use has become widespread with their
misuse being an ever-increasing phenomenon. Consequently, antibacterial drugs have …

[HTML][HTML] Colistin for lung infection: an update

M Gurjar - Journal of intensive care, 2015 - Springer
Increasing incidence of resistance of gram-negative bacteria against even newer antibiotic
including carbapenem has generated interest in the old antibiotic colistin, which are being …